Key facts
- This page summarizes Peter S. Garcia's Form 4 filing for ALX ONCOLOGY HOLDINGS INC (ALXO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 16 Feb 2024, 18:21.
Peter S. Garcia - 14 Feb 2024 Form 4 Insider Report for ALX ONCOLOGY HOLDINGS INC (ALXO)
- Reporting relationship
- CHIEF FINANCIAL OFFICER
- Issuer ticker
- ALXO
- Reported as of
- 14 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 16 Feb 2024, 18:21:00 UTC
- Prior SEC filing
- 03 Jan 2024
- Next SEC filing
- 17 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Peter Garcia
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Peter S. Garcia filed Form 4 for ALX ONCOLOGY HOLDINGS INC (ALXO) on 16 Feb 2024.
Change
- Previous filing in this sequence was filed on 03 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ALXO
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +25,000
- Change %
- +29%
- Price
- $0.000000
- Shares after
- 110,348
- Date
- 14 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ALXO
transaction
Derivative
Employee Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +80,000
- Change %
- Price
- $0.000000
- Shares after
- 80,000
- Date
- 14 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 80,000
- Exercise price
- $15.84
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024.
Footnote F2
Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.